I. Introduction
===============

The basement membrane is an extracellular scaffold for cells, aids in structural support of many tissues, and also functions as a barrier between tissues. Cell-basement membrane interactions are involved in proliferation, adhesion, migration, and differentiation of cells during embryonic morphogenesis and in adult tissues. The basement membrane has four major components: laminin, type IV collagen, nidogen, and heparan sulfate proteoglycan \[[@B26]\]. Laminin is required for basement membrane assembly and is made up of three subunits, namely, α, β, and γ chains \[[@B1], [@B4]\]. There are five α (α1-5), three β (β1-3), and three γ (γ1-3) chains, and combinations of these chains assemble into 19 different laminin isoforms \[[@B6]\]. Among these laminin chains, the α chains are thought to be the major determinant of laminin function, since they have C-terminal laminin globular (LG) domains, which bind the laminin receptors \[[@B26]\].

The anterior pituitary gland is composed of five types of hormone-secreting cells and folliculo-stellate cells, which do not produce classical anterior pituitary hormones. The gland arises from a primordial tissue termed Rathke's pouch, a thickened primordial oral ectoderm in the embryo. Recently, using *in situ* hybridization, our research group showed that laminin chain expression differed in the embryonic and postnatal rat pituitary gland \[[@B21]\]. In that study, laminin isoforms containing the α5 chain appeared to have an important role in gland development, since the laminin α5 chain is the first α chain expressed by primordial tissue in the gland. The function of laminin isoforms containing the α5 chain is believed to involve enhancing the structural integrity of the basement membrane during organogenesis \[[@B23]\]. In addition, recombinant laminins containing the α5 chain were involved in self-renewal of embryonic stem cells \[[@B5]\]. However, little is known of the distribution of the laminin α5 chain or the existence of its receptor in the pituitary gland. Furthermore, the function of laminin isoforms containing the α5 chain remains unclear. Using immunohistochemical techniques, we investigated the distribution of the laminin α5 chain and its specific receptor, basal cell adhesion molecule (BCAM), in both fetal and adult rat pituitary glands.

II. Materials and Methods
=========================

Animals
-------

Adult Wistar rats were purchased from Japan SLC (Shizuoka, Japan). The animals were maintained under a 12-hr light/dark cycle and given conventional food and water *ad libitum*. Room temperature was maintained at approximately 22°C. The day on which spermatozoa were identified in a vaginal smear was designated as embryonic day 0.5 (E0.5). The date of birth was designated as postnatal day 0 (P0). All animal experiments were performed after receiving approval from the Institutional Animal Experiment Committee of Jichi Medical University and were conducted in accordance with the Institutional Regulations for Animal Experiments and Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the Jurisdiction of the Japanese Ministry of Education, Culture, Sports, Science and Technology.

Tissue preparation
------------------

Cryosections of freshly frozen tissue were used for immunostaining the laminin α5 chain. Pregnant rats were anesthetized with pentobarbital sodium (25 mg per kg body weight, i.p., Kyoritsu Seiyaku, Tokyo, Japan) when their fetuses reached E12.5, E13.5, E14.5, E15.5, E16.5, E17.5, E18.5, and E19.5. Pituitary glands were excised from P3 and P60 male rats under deep anesthesia. At each stage, four animals were used for analysis. The resected fetuses and excised pituitary glands were embedded in Tissue-Tek OTC compound and frozen in liquid nitrogen. Sagittal sections of fetuses and frontal sections of the pituitary glands (thickness 4 μm) were obtained with a cryostat (CM3000; Leica Microsystems, Wetzlar, Germany) and mounted on glass slides. Before immunohistochemistry, sections were fixed in ice-cold methanol for 10 min.

The pituitary glands were excised from four P60 male rats that were perfused through the left ventricle with 4% paraformaldehyde in 0.05 M phosphate buffer (pH 7.4) for 5 min under anesthesia. The glands were then immersed in the same fixative for 24 hr at 4°C. The glands were subsequently dehydrated, embedded in paraffin, and cut into frontal sections (thickness 2 μm) with an ultramicrotome (Ultracut UCT; Leica Microsystems). After deparaffinization, sections were incubated in an Immunosaver (Nisshin EM, Tokyo, Japan) for 60 min at 95°C for antigen retrieval, then immunostained for S100 protein and isolectin 4B.

Immunohistochemistry
--------------------

Sections were blocked with phosphate-buffered saline (PBS) containing 5% skim milk for 30 min at 30°C and incubated in PBS with primary antibodies, including rabbit anti-human laminin α5 (Santa Cruz Biotechnology, Santa Cruz, CA, USA; dilution, 1:20), goat anti-mouse BCAM (R&D Systems, Minneapolis, MN, USA; dilution, 1:400), and rabbit anti-S100 protein (DAKO, Glostrup, Denmark; dilution, 1:200), a marker of folliculo-stellate cells. For double immunostaining, Alexa Fluor 488-conjugated goat anti-rabbit IgG and Alexa Fluor 568-conjugated donkey anti-goat IgG (Thermo Fisher Scientific, Waltham, MA, USA) were used as secondary antibodies. Alexa Fluor 488-labeled isolectin B4 (Thermo Fisher Scientific), a marker of endothelial cells, was used for lectin histochemistry. Stained sections were subsequently cover-slipped with Vectashield HardSet mounting medium with 4\',6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA, USA) and observed with a confocal laser microscope (FV1000, Olympus, Tokyo, Japan). The absence of an observable nonspecific immunoreaction was confirmed by incubating sections with normal serum from either rabbit or goat, instead of the primary antibody, and then with the secondary antibody.

Real-time PCR quantification of laminin α5 chain and BCAM mRNA levels
---------------------------------------------------------------------

Anterior pituitary glands were obtained from male rats at P3, P5, P10, P20, P30, and P60. Four pituitary glands were analyzed in each group. Total RNA was extracted with a RNeasy mini-kit and a RNase-free DNase set, according to the manufacturer's instructions (Qiagen, Hilden, Germany). cDNA was synthesized by using the PrimeScript RT reagent kit (Takara Bio, Shiga, Japan) with an oligo-(dT)20 primer. Quantitative real-time PCR (ABI PRISM 7900HT, Applied Biosystems, Foster City, CA, USA) was performed using the specific primers and SYBR Premix Ex Taq (Takara Bio) containing SYBR Green I. Primers were used to amplify laminin α5 chain cDNA fragments (GenBank accession no. NM_001191609): forward 5\'-GGA TCA TGC TGA CTA CTA TGG-3\' and reverse 5\'-GCA GGT CTG GCA AGT AGT G-3\' (161 bp) and to amplify BCAM (GenBank accession no. BC072479): forward 5\'-AGT CAG CGT CGG TCT CTT G-3\' and reverse 5\'-GTG TGT TCT GGA CGC TCT G-3\' (166 bp). For normalization of laminin α5 chain and BCAM mRNA levels, the mRNA levels of glyceraldehyde-3-phosphate dehydrogenase (GAPDH, GenBank accession no. AF106860): forward 5\'-AAG GGC TCA TGA CCA CAG TC-3\' and reverse 5\'-GGA TGC AGG GAT GAT GTT CT-3\' (116 bp) were determined. All measurements were made in duplicate, and the relative quantification was conducted using the standard curve method.

III. Results
============

Localization of the laminin α5 chain and BCAM in the embryonic pituitary gland
------------------------------------------------------------------------------

Double immunohistochemistry was used to compare the localization of the laminin α5 chain and BCAM in the embryonic pituitary gland. The laminin α5 chain was present in the basement membrane of the adenohypophyseal placode at E12.5 ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}), and the epithelial cells of this tissue expressed BCAM ([Supplementary Fig. 2](#SD2){ref-type="supplementary-material"}). At E12.5 and E13.5, the laminin α5 chain and BCAM co-localized on the basal side of the epithelial cells of both the oral ectoderm and Rathke's pouch but not on the apical or lateral sides of the cells ([Fig. 1](#F1){ref-type="fig"}a--h). The adenohypophysis is formed from the pars distalis, pars tuberalis, and pars intermedia. The adenohypophysis was surrounded by laminin α5 chain immunoreactivity at E14.5 ([Fig. 1](#F1){ref-type="fig"}i). Laminin α5 chain immunoreactivity was also detected inside the pars distalis at E16.5, E17.5, E18.5, and E19.5, and immunoreactivity increased with development ([Fig. 2](#F2){ref-type="fig"}a, e, i, m). BCAM immunoreactivity was present in the area adjacent to the adenohypophysis and on cells of both the pars intermedia and superior pars distalis at E14.5, E15.5, E16.5, E17.5, E18.5, and E19.5 ([Fig. 1](#F1){ref-type="fig"}j, n, [Fig. 2](#F2){ref-type="fig"}b, f, j, n). From E16.5 to E19.5, BCAM and laminin α5 chain immunoreactivity were observed inside the pars distalis. Additionally, the intensity of BCAM immunoreactivity in the pars tuberalis was weaker than that in other parts of the adenohypophysis at E15.5 and E16.5, and the immunoreactivity had mostly disappeared in the pars tuberalis at E17.5, E18.5, and E19.5. The laminin α5 chain and BCAM co-localized in the area surrounding the adenohypophysis at E14.5, E15.5, E16.5, E17.5, E18.5, and E19.5 and inside the pars distalis at E16.5, E17.5, E18.5, and E19.5 ([Fig. 1](#F1){ref-type="fig"}k, l, o, p, [Fig. 2](#F2){ref-type="fig"}c, d, g, h, k, l, o, p). In the neurohypophysis (neurohypophyseal bud or pars nervosa), only laminin α5 chain immunoreactivity was observed.

Postnatal expression of the laminin α5 chain and BCAM in the rat anterior pituitary
-----------------------------------------------------------------------------------

Both laminin α5 chain and BCAM immunoreactivity were observed in the rat anterior pituitary gland at P3, and the signals were partially co-localized ([Fig. 2](#F2){ref-type="fig"}q--t). Real-time PCR was used to determine the levels of transcripts for the laminin α5 chain and BCAM present in the glands at postnatal stages. The relative levels of laminin α5 chain mRNA in the rat anterior pituitary gland gradually decreased throughout growth ([Fig. 3](#F3){ref-type="fig"}a), as did expression levels of BCAM mRNA ([Fig. 3](#F3){ref-type="fig"}b). In quantitative analysis, both transcripts were detectable at P60.

Immunohistochemical techniques were used to confirm the existence of the laminin α5 chain and BCAM in the anterior pituitary gland of the adult rat. Double immunohistochemistry revealed that the laminin α5 chain and BCAM were present in the anterior, intermediate, and posterior lobes at P60 ([Fig. 4](#F4){ref-type="fig"}a--c). In the anterior lobe, laminin α5 chain and BCAM immunoreactivity were located in the area surrounding blood vessels and in the parenchyma ([Fig. 4](#F4){ref-type="fig"}d, e). The laminin α5 chain and BCAM were partially co-localized in the gland ([Fig. 4](#F4){ref-type="fig"}f).

Characterization of BCAM-expressing cells in the anterior pituitary gland
-------------------------------------------------------------------------

Double immunohistochemistry was used to identify cells expressing BCAM. BCAM immunoreactivity in the parenchyma of the anterior lobe was located on folliculo-stellate cells, which were identified by immunohistochemistry for S100 protein ([Fig. 5](#F5){ref-type="fig"}a--c). BCAM immunoreactivity around blood vessels of the anterior lobe was located on endothelial cells, which were identified by immunohistochemistry for isolectin B4 ([Fig. 5](#F5){ref-type="fig"}d--f). BCAM immunoreactivity was not detected in any type of endocrine cell ([Supplementary Fig. 3](#SD3){ref-type="supplementary-material"}).

IV. Discussion
==============

This is the first report to describe the distribution of the laminin α5 chain and its specific receptor, BCAM, in the rat pituitary gland. Immunohistochemical analysis showed that the laminin α5 chain is co-localized with BCAM in the gland throughout tissue development. In addition, folliculo-stellate cells and endothelial cells express BCAM in the adult anterior pituitary gland.

Rathke's pouch is composed of undifferentiated cells, which are committed to become the adenohypophysis through cell proliferation and differentiation. This tissue is surrounded by a basement membrane. Our immunohistochemical study showed that laminins containing the α5 chain are distributed in the basement membrane of the embryonic adenohypophysis, including Rathke's pouch ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}, [Fig. 1](#F1){ref-type="fig"}a, e, i, m, [Fig. 2](#F2){ref-type="fig"}a, e, i, m). This distribution pattern is similar to those reported for both type IV collagen and laminin \[[@B2], [@B10]\].

BCAM, also known as the Lutheran blood glycoprotein, is a membrane protein in the immunoglobulin superfamily. It binds to the LG domains of the laminin α5 chain and is a specific receptor for laminins containing that chain \[[@B7], [@B17], [@B25]\]. In the present study, co-localization of BCAM and the laminin α5 chain suggested that the BCAM of epithelial cells in the primordial adenohypophysis functions as a receptor for this laminin chain (Figs. [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). Our previous study reported that the α5 chain is produced in epithelial cells of the primordial adenohypophysis \[[@B21]\]. These findings suggest that cells of the primordial adenohypophysis respond in an autocrine manner to endogenously produced laminin α5 chain via BCAM and that this signal may contribute to basement membrane development and maintenance. In contrast, the embryonic neurohypophysis exhibited only laminin α5 chain immunoreactivity, and the disappearance of BCAM immunoreactivity in the pars tuberalis of adenohypophysis at E16.5, E17.5, E18.5, and E19.5 suggests either that laminin α5 chain-mediated signaling via BCAM is not involved in neurohypophysis and pars tuberalis development or cells in this region have other receptors for the chain.

Our observation of laminin α5 chain and BCAM immunoreactivity inside the gland from E16.5 to E19.5 is similar to that regarding the reported location of capillaries ([Fig. 2](#F2){ref-type="fig"}a--p). After E16.5, capillaries invade the rat pars distalis from circumferential interstitial tissue \[[@B8]\]. In addition, a study using conditional knock-out mice found that integrin β1, a common receptor of several extracellular matrix molecules, including laminin, is required for developmental angiogenesis in the pituitary gland \[[@B22]\]. Regarding the mechanism, BCAM appeared to regulate cell migration by competitively modulating integrin binding to the laminin α5 chain in a human fibrosarcoma cell line \[[@B18]\]. Past and present evidence suggests that BCAM may regulate the integrin signal involved in capillary invasion of the pars distalis.

Our previous study using *in situ* hybridization revealed that laminin α5 chain mRNA is also expressed in the cells of the rat anterior pituitary gland at P5, P10, and P30 \[[@B21]\]. In the present study, quantitative analysis for laminin α5 mRNA and immunohistochemical analysis revealed that laminin α5 is present in the gland postnatally, including in adult rats at P60 ([Fig. 2](#F2){ref-type="fig"}q, [Fig. 3](#F3){ref-type="fig"}a, [Fig, 4](#F4){ref-type="fig"}a, d) and that its distribution is similar to the localization of laminin in the gland, as previously reported \[[@B9], [@B24]\]. To better understand how the amount of the laminin α5 chain is controlled, future studies should attempt to identify both the cells producing it in the gland and the systems that regulate its expression.

This study additionally revealed postnatal BCAM expression in the rat anterior pituitary gland. Furthermore, we found evidence that these receptor-expressing cells may contact the basement membrane containing the laminin α5 chain, as indicated by co-localization of the immunoreactivity ([Fig. 2](#F2){ref-type="fig"}q--t, [Fig. 3](#F3){ref-type="fig"}b, [Fig. 4](#F4){ref-type="fig"}). BCAM is expressed in human dermal keratinocytes and murine glomerular endothelium \[[@B3], [@B16]\]. In the adult rat anterior pituitary gland, folliculo-stellate cells and endothelial cells expressed BCAM ([Fig. 5](#F5){ref-type="fig"}). We previously reported that folliculo-stellate cell functions are influenced by the interaction between the cell and laminin via integrin β1 \[[@B12], [@B13]\]. Integrin β1 expressed in endothelial cells is involved in angiogenesis \[[@B19]\]. These past and present results suggest that BCAM may contribute to the functions of both folliculo-stellate cells and endothelial cells by regulating integrin signaling in the adult rat anterior pituitary gland.

Our previous studies showed that laminin α chains other than α5, including α1 through α4, are expressed during gland development \[[@B20], [@B21]\], but their distributions and the functional differences between them are unclear. In addition, various laminin receptors, including integrins and syndecans, may be involved in regulating anterior pituitary cell function \[[@B11], [@B14], [@B15]\]. Future studies should attempt to clarify the functions of these laminin α chains and their receptors in the gland.
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Supplementary Materials
=======================

###### Supplementary Fig. 1.

Distribution of the laminin α5 chain in the rat adenohypophyseal placode at embryonic day 12.5. Sagittal methanol-fixed cryosections were prepared. **a**: Hematoxylin and eosin staining of a section. Sections were incubated in phosphate-buffered saline with rabbit anti-human laminin α5 (Santa Cruz Biotechnology, Santa Cruz, CA, USA; dilution, 1:20) as a primary antibody. For double immunostaining, Alexa Fluor 488-conjugated goat anti-rabbit IgG (Thermo Fisher Scientific, Waltham, MA, USA) was used as a secondary antibody. Rabbit anti-mouse type IV collagen (Cosmo Bio, Tokyo, Japan; dilution, 1:120) was labeled with Alexa Fluor 568 by Zenon^®^ Complex Formation/Labeling reagent (Thermo Fisher Scientific), according to the manufacturer's instructions, and used for immunostaining. **b--d** are confocal double immunohistochemistry images for the laminin α5 chain (green) and type IV collagen (red). **b** shows laminin α5 chain immunoreactivity. **c** shows immunoreactivity of type IV collagen, a major basement membrane component. **d** is a merged image of **b** and **c**. RP, Rathke's pouch; NB, neurohypophyseal bud. Bar = 100 μm (**a--d**). Laminin α5 chain immunoreactivity was detected on the basal side of epithelial cells from the oral ectoderm and Rathke's pouch and was co-localized with type IV collagen immunoreactivity. The laminin α5 chain and type IV collagen were also present in the neurohypophyseal bud.

###### Supplementary Fig. 2.

Expression and distribution of basal cell adhesion molecule (BCAM) at embryonic day 12.5 (E12.5) in rat. **a**: Hematoxylin and eosin staining of a cryosection (thickness 8 μm) of the whole body at E12.5. **b**: *In situ* hybridization of BCAM mRNA. Digoxigenin-labeled cRNA probes were made from an amplified DNA fragment of BCAM (GenBank accession no. BC072479) using the following primers: forward 5\'-TGA CTC TGT GAC CTT CGA CTC-3\' and reverse 5\'-GCC TTC CGT CCA GCT AGT G-3\' (588 bp), then used for *in situ* hybridization with 4-nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate (*blue*; Roche Diagnostics, Penzberg, Germany). **c**: BCAM immunoreactivity at E12.5. Goat anti-mouse BCAM (R&D Systems, Minneapolis, MN, USA; dilution, 1:400) was used as the primary antibody, and the ABC method (Vector Laboratories, Burlingame, CA, USA), with 3,3\'-diaminobenzidine (Dojindo Laboratories, Kumamoto, Japan) as substrate, was used for observing the immunoreaction (brown) of BCAM. **d**: High-magnification image of the adenohypophyseal placode (box in **a**). **e**: High-magnification image of the adenohypophyseal placode (box in **b**). **f**: High-magnification image of the adenohypophyseal placode (box in **c**). RP, Rathke's pouch; NB, neurohypophyseal bud. Bars = 1 mm (**a--c**), 100 μm (**d--f**). BCAM mRNA was expressed in epithelial cells of the oral ectoderm and Rathke's pouch but not in the neurohypophyseal bud. A positive signal was observed only in the cell cytoplasm. BCAM immunoreactivity was detected in the epithelial cell membranes located in the region of the *in situ* hybridization signal.

###### Supplementary Fig. 3.

Endocrine cells did not express basal cell adhesion molecule (BCAM) in the rat anterior pituitary gland at P60. The primary antibodies used in the experiments were rabbit anti-porcine adrenocorticotrophic hormone 1--39 (ACTH; Dr. Nakamura, Hokkaido University, Hokkaido, Japan; dilution, 1:3,200), anti-rat growth hormone (GH; Dr. K. Wakabayashi, Gunma University, Gunma, Japan; dilution, 1:5,000), anti-rat prolactin (Dr. K. Wakabayashi, Gunma University, Gunma, Japan; dilution, 1:10,000), anti-rat thyroid-stimulating hormone (TSH) β subunit (Dr. K. Wakabayashi, Gunma University, Gunma, Japan; dilution, 1:8000), anti-ovine luteinizing hormone (LH) β subunit (Dr. K. Wakabayashi; dilution, 1:2500). **a--c**: Double immunostaining of ACTH (**a**, green) and BCAM (**b**, red) in the anterior pituitary gland. **d--f**: Double immunostaining of GH (**d**, green) and BCAM (**e**, red) in the anterior pituitary gland. **g--i**: Double immunostaining of prolactin (**g**, green) and BCAM (**e**, red) in the anterior pituitary gland. **j--l**: Double immunostaining of TSHβ (**j**, green) and BCAM (**l**, red) in the anterior pituitary gland. **m--o**: Double immunostaining of LHβ (**j**, green) and BCAM (**l**, red) in the anterior pituitary gland. Bar = 10 μm (**a--o**).

![Double immunohistochemistry of the laminin α5 chain and basal cell adhesion molecule (BCAM) in the developing rat pituitary gland at embryonic day 12.5 (E12.5, **a--d**), E13.5 (**e--h**), E14.5 (**i--l**), and E15.5 (**m--p**). Sagittal methanol-fixed cryosections were prepared. **a**, **e**, **i**, and **m** show laminin α5 chain immunoreactivity (green). **b**, **f**, **j**, and **n** show BCAM immunoreactivity (red). **c**, **g**, **k**, and **o** are merged images of **a** and **b**, **e** and **f**, **i** and **j**, and **m** and **n**, respectively. **d**, **h**, **l**, and **p** are high-magnification views of the *boxes* in **c**, **g**, **k**, and **o**, respectively. RP, Rathke's pouch; NB, neurohypophyseal bud; PD, pars distalis; PT, pars tuberalis; PI, pars intermedia; PN, pars nervosa. Bars = 100 μm (**a--c**, **e--g**, **i--k**, **m--o**) and 10 μm (**d**, **h**, **l**, **p**).](AHC18014f01){#F1}

![Double immunohistochemistry of the laminin α5 chain and BCAM in the developing rat pituitary gland at E16.5 (**a--d**), E17.5 (**e--h**), E18.5 (**i--l**), E19.5 (**m--p**), and postnatal day 3 (P3, **q--t**). Sagittal (E16.5--19.5) and frontal (P3) methanol-fixed cryosections were prepared. **a**, **e**, **i**, **m**, and **q** show laminin α5 chain immunoreactivity (green). **b**, **f**, **j**, **n**, and **r** show BCAM immunoreactivity (red). **c**, **g**, **k**, **o**, and **s** are merged images of **a** and **b**, **e** and **f**, **i** and **j**, **m** and **n**, and **q** and **r**, respectively. **d**, **h**, **l**, **p**, and **t** are high-magnification views of the *boxes* in **c**, **g**, **k**, **o**, and **s**, respectively. PD, pars distalis; PT, pars tuberalis; PI, pars intermedia; PN, pars nervosa; AL, anterior lobe; IL, intermediate lobe; PL, posterior lobe. Bars = 100 μm (**a--c**, **e--g**, **i--k**, **m--o**, **q--s**) and 10 μm (**d**, **h**, **l**, **p**, **t**).](AHC18014f02){#F2}

![Postnatal changes in laminin α5 chain and BCAM mRNA levels in the rat anterior pituitary gland, as determined by real-time PCR. Laminin α5 chain and BCAM mRNA levels at P3, P5, P10, P20, P30, and P60 were normalized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA level as an internal control. Four animals were used for each analysis at each stage. Data are expressed as mean ± SEM (n = 4).](AHC18014f03){#F3}

![Double immunohistochemistry of the laminin α5 chain and BCAM in the rat pituitary gland at P60. Frontal-plane methanol-fixed cryosections were prepared. **a** and **d** show laminin α5 chain immunoreactivity (green). **b** and **e** show BCAM immunoreactivity (red). **c** and **f** are merged images of **a** and **b**, and **d** and **e** respectively. **d--f** are high-magnification views of the anterior lobe (AL). IL, intermediate lobe; PL, posterior lobe. Bars = 100 μm (**a--c**), 10 μm (**d--f**).](AHC18014f04){#F4}

![BCAM-expressing cells in the rat anterior pituitary gland at P60. **a--c**: Double immunostaining of S100 protein (**a**, a marker of folliculo-stellate cells, green) and BCAM (**b**, red) in the anterior pituitary gland. **d--f**: Double immunostaining of isolectin B4 (**d**, a marker of endothelial cells, green) and BCAM (**e**, red) in the anterior pituitary gland. Bar = 10 μm (**a--f**).](AHC18014f05){#F5}
